Now with Neuren’s P/E ratio at 4733, I’m going to have to recalculate my forecasts for when we’re making $100M!
- Forums
- ASX - By Stock
- NEU
- Ann: Neuren reports 2022 full-year results
NEU
neuren pharmaceuticals limited
Add to My Watchlist
1.83%
!
$13.09

Ann: Neuren reports 2022 full-year results, page-7
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$13.09 |
Change
0.235(1.83%) |
Mkt cap ! $1.628B |
Open | High | Low | Value | Volume |
$13.15 | $13.37 | $12.92 | $5.197M | 396.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 878 | $13.08 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.09 | 321 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 813 | 13.080 |
6 | 623 | 13.070 |
15 | 1620 | 13.060 |
13 | 5042 | 13.050 |
5 | 1320 | 13.040 |
Price($) | Vol. | No. |
---|---|---|
13.090 | 503 | 4 |
13.100 | 553 | 6 |
13.110 | 913 | 7 |
13.120 | 1490 | 8 |
13.130 | 1533 | 8 |
Last trade - 13.59pm 18/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online